Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study.

@article{Hennessy1996EffectivenessOL,
  title={Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study.},
  author={Sean Hennessy and Zhi-Qiang Liu and Theodore F. Tsai and Brian L. Strom and Chuan Wan and Howard L Liu and Tai-xiang Wu and Hang Yu and Q M Liu and Nick Karabatsos and Warren B. Bilker and Scott B. Halstead},
  journal={Lancet},
  year={1996},
  volume={347 9015},
  pages={1583-6}
}
BACKGROUND Japanese encephalitis is a major cause of death and disability throughout Asia, including the Indian subcontinent. Although an effective vaccine for Japanese encephalitis is available, hundreds of millions of susceptible individuals remain unimmunised because of the vaccine's cost. In 1988, an inexpensive live-attenuated vaccine (SA14-14-2) was licensed in China. We have measured the effectiveness of this vaccine. METHODS In a case-control study in rural Sichuan Province, China… CONTINUE READING